Navigation Links
Hospira Advances Patient Safety With New GemStar(R) SP Infusion System
Date:2/25/2009

- Safety Protocol Integration Enhances Market-Leading GemStar Medication Management Pump -

LAKE FOREST, Ill., Feb. 25 /PRNewswire-FirstCall/ --Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced the introduction of the GemStar(R) SP infusion system with GemStar(TM) Infusion Suite software, an advanced version of the market-leading, multi-application, GemStar pump. The GemStar SP infusion system is designed to help caregivers better incorporate patient safety best practices right at the patient's bedside.

GemStar SP incorporates GemStar Infusion Suite software, a stand-alone personal computer (PC)-based application designed to enhance safe and efficient medication administration. In an effort to help clinicians combat the 1.5 million medication errors that occur annually(1), GemStar SP allows healthcare facilities to tailor the pump to meet specific clinical objectives.

The compact and portable pump has configurable settings to help streamline the programming process for clinicians and provide flexible drug protocols with hard limits to help prevent medication errors. GemStar also offers several security features including four keypad lockouts, integral set-based free flow protection and mandatory confirmation screens, to help minimize the risk of medication delivery errors.

"The new GemStar Infusion Suite software allows clinicians to quickly recall a pre-configured drug safety suite for safer, and more efficient drug delivery," said Steven Pregulman, M.D., global medical director, Device Development, Hospira. "The advancements made with GemStar SP reinforce Hospira's position as a leading provider of safety medication administration products for all infusion needs."

With the addition of GemStar SP to the product line, Hospira now offers safety software in all of its leading infusion system families. This new product also completes Hospira's pain management solution, making Hospira the only manufacturer of medication management systems (MMS) to offer a complete pain management system.

GemStar - One of the Most Versatile Ambulatory Infusion Pumps

The GemStar line of products offers three therapy-specific models which can be used for parenteral infusions, intravenous (I.V.) solutions, medications, nutritional fluids and blood/blood products. The pumps provide single-channel administration of up to seven different therapies and feature custom configurations to streamline programming. Currently, Hospira has more than 50,000 GemStar infusion systems in use at hospitals and healthcare institutions around the world.

With its rugged design and lightweight aluminum frame, Hospira's GemStar pump is compact and portable enough to be used anywhere in the hospital -- from labor and delivery units to critical medical transport missions and homecare and ambulatory settings. The devices are designed to help enhance the safety, simplicity and reliability of infusions across all applications.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at www.hospira.com.

(1) IOM. 2007. Preventing Medication Errors. Washington, DC: National Academy Press.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Biogenerics Will Save Billions, Says Hospira CEO
2. Hospiras Biosimilar Epoetin Retacrit(TM) Receives Positive Opinion Recommending EU Approval
3. Hospira Expands Board of Directors
4. Human Genome Sciences Announces Process Development and Manufacturing Alliance With Hospira
5. Hospira Hosts Conference Call for Third-Quarter 2008 Earnings
6. StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists
7. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
8. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
9. Verenium Advances Its Development Work With Cargill on a New Food-Related Product
10. EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference
11. Response Genetics CEO to Discuss Advances in Optimizing Therapy through Pharmacogenomics as Part of a Series of Presentations at AACR-NCI-EORTC International Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2017)... ... May 19, 2017 , ... ... Academic researchers with technologies ripe for commercialization, and who are affiliated with ... are encouraged to submit proposals. QED, now in its tenth round, is the ...
(Date:5/18/2017)... ... May 16, 2017 , ... Clinical Supplies Management (“CSM”), a Great ... company continues to grow. CSM has doubled in size over the past six ... aggressive growth strategy. , Roger Gasper joins CSM as Chief Financial Officer. Roger ...
(Date:5/18/2017)... Massachusetts (PRWEB) , ... May 17, 2017 , ... ... company specializing in medical device compliance and commercialization, has just released version 9.0 ... of work into this latest version of Cockpit,” says David Cronin, CEO of ...
(Date:5/18/2017)... College Station, TX (PRWEB) , ... May 17, ... ... cleanroom design and construction, announced today that their Chief Executive Officer, Maik Jornitz, ... Power List. The UK publication’s Power List celebrates 100 individuals “involved in bettering ...
Breaking Biology Technology:
(Date:4/13/2017)... 2017 According to a new market research report ... Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region ... expected to grow from USD 14.30 Billion in 2017 to USD 31.75 ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
Breaking Biology News(10 mins):